Rocketman

Jafron Biomedical: 300529

Long
Rocketman Updated   
SZSE:300529   JAFRON BIOMEDICAL
Fundamentals:
Company website: www.jafron.com

About: Jafron Biomedical company researches and produces hemoperfusion-related products, which helps to reduced blood pressure in patients. Jafron is number one among its peers in its industry within mainland China.
This company has a strong and stable balance sheet and it is making money. It is set to continue to grow well into 2021.

Technicals:
Volume accumulations within a chart base pattern
Breakout

What I will do:
Buy and hold until next earnings season and guidance from upper management

Comment:

Capturing the swings of the stock market & currency market. It's a dirty job and equity/currency traders must do it.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.